{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02234869: Phase 4 Interventional Withdrawn Relapsing Multiple Sclerosis
(2014)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT03721081: Phase 4 Interventional Completed Anesthesia, Local
(2014)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT01299350: Phase 4 Interventional Completed Heart Failure
(2010)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Ann Hematol. Jun 2016;95(7):1077-87.: Phase 4 Human clinical trial Completed Purpura, Thrombocytopenic, Idiopathic/metabolism/pathology
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02643147: Phase 4 Interventional Completed Heart Failure
(2015)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT01347996: Phase 4 Interventional Completed Acute Myeloid Leukemia
(2009)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT02497118: Phase 4 Interventional Completed Non Small Cell Lung Cancer
(2010)
Source URL:
Class:
PROTEIN
